Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipients
- 1 February 1997
- journal article
- clinical trial
- Published by Elsevier in Transplantation Proceedings
- Vol. 29 (1-2) , 649-651
- https://doi.org/10.1016/s0041-1345(96)00380-6
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- RESCUE THERAPY WITH TACROLIMUS AFTER COMBINED KIDNEY/PANCREAS AND ISOLATED PANCREAS TRANSPLANTATION IN PATIENTS WITH SEVERE CYCLOSPORINE NEPHROTOXICITY1Transplantation, 1996
- A MULTICENTER ANALYSIS OF THE FIRST EXPERIENCE WITH FK506 FOR INDUCTION AND RESCUE THERAPY AFTER PANCREAS TRANSPLANTATION1Transplantation, 1996
- NORMAL PANCREAS ALLOGRAFT FUNCTION FOLLOWING SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION AFTER RESCUE THERAPY WITH TACROLIMUS (FK506)Transplantation, 1995
- A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver TransplantationNew England Journal of Medicine, 1994
- Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejectionThe Lancet, 1994
- Combined Kidney and Pancreas TransplantationArchives of Surgery, 1992
- Experience With 100 Consecutive Simultaneous Kidney-Pancreas Transplants With Bladder DrainageAnnals of Surgery, 1991
- MORBIDITY OF PANCREAS TRANSPLANTATION DURING CADAVERIC RENAL TRANSPLANTATIONTransplantation, 1991
- FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATIONThe Lancet, 1989
- Role of brain in counterregulation of insulin-induced hypoglycemia in dogsDiabetes, 1989